Amendment 164
Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest
A10-0272/2025 – Tomislav Sokol – Amendments by the committee responsible – separate vote – Am 164
Adopted
- For
- 450
- Against
- 205
- Abstained
- 8
roll-call vote at 12:46 · 68% of votes cast in favour
Roll call requested by Patriots
How the groups voted
A group’s line is the position at least two thirds of its voting MEPs took; otherwise it is shown as Divided. Groups from left to right.
| Group | For | Against | Abstained | of | Line |
|---|---|---|---|---|---|
| The Left | 3 | 35 | 0 | 38 | Against |
| Greens | 50 | 0 | 0 | 50 | For |
| S&D | 76 | 48 | 0 | 124 | Divided |
| Renew | 62 | 5 | 0 | 67 | For |
| EPP | 177 | 4 | 1 | 182 | For |
| ECR | 62 | 10 | 1 | 73 | For |
| Patriots | 7 | 72 | 0 | 79 | Against |
| ESN | 0 | 24 | 0 | 24 | Against |
| No group | 13 | 7 | 6 | 26 | — |
“of” = MEPs of the group who voted. Groups as they are now.
Every MEP
26 MEPs of 663 Clear filters
“Votes in which an MEP voted differently from their group: on decision pages, against a line at least two thirds of the group took; in loyalty figures, against the position most of the group took.” = voted otherwise than a clear line (two thirds of its votes) of the group they sit in now. MEPs with no vote recorded are not listed.